Jim Scully

Experience

• 

  Abbott

  Jan 1992 - Jan 1998

  Reported to Plant Director. Directed the budgeting, standard setting, monthly close, service department allocations, performance reporting, capital spending justification and all other financial analysis at $140 million (throughput) dry products and $30 million liquids facilities. Reported to Commercial Controller. Responsible for planning, analysis and control of over $250 million in Sales Force and Marketing spend. Successfully expanded the group’s charter to include analytical leadership of strategic resource allocation and investment optimization projects, with aim of increasing revenue impact of fixed budgets.

  • Plant Controller

    Jan 1996 - Jan 1998

  • Manager, Commercial Financial Analysis

    Jan 1992 - Jan 1996
• 

  KV Pharmaceutical

  Jan 1998 - Jan 1999

  Director of Strategic Planning

  Reported to CEO. Responsible for corporate performance reporting and analysis, operating issues resolution, objectives setting and tracking, and long-range planning. Also involved in product acquisitions, including setting of search criteria, financial modeling, coordination of due diligence, terms proposal, contracting and integration.

• 

  Takeda

  Jan 1999 - Jan 2009

  Led global project to determine feasibility, design and justification to acquire or build a U.S.-based packaging facility to support commercial and clinical requirements. Reported to EVP, Global Production Division. Global project leader providing identification, analysis, valuation, diligence, negotiation and contracting of licensing, M&A, joint ventures, co-promotion and other strategic alliances. Reported to VP Global Business Development. Led the financial planning process and presentation to parent, 5-year strategic plan, annual report, analysis of monthly operating results, and all other financial analysis for commercial and clinical development operations.

  • Senior Director, Corporate Project Management

    Jan 2008 - Jan 2009

  • Senior Director, Global Business Development (Franchise Lead)

    Jan 2003 - Jan 2008

  • Director, Financial Planning & Analysis

    Jan 1999 - Jan 2003
• 

  Independent Consultant

  Jan 2010 - Jan 2011

  Principal / Project Leader

  Engaged by several healthcare companies and consultancies. Deliverables included product performance analytics, business KPI and dashboard design, new product portfolio analytics, creation of pricing tool for field Sales, and transaction advisory services.

• 

  Walgreens

  Jan 2011 - Jan 2015

  Business and operational leader of Walgreens patient recruitment and other services, in support of pharma company clinical trials. This P&L-responsible role included business development, pricing strategy, proposal design, negotiations, contracting and management of project teams. Strategic Finance & Planning lead for 180-person Managed Markets Sales group and 90-person Pricing & Contracting group. Role included leadership of organization size and structure analytics, sales forecasting, goal-setting, incentive plan design and performance reporting. Also, key member of strategic pricing and contracting teams. Finance lead for Chief Medical Officer’s 100-person Clinical Office and Healthcare Partnership group. Role included leadership of business case analytics, planning and performance reporting for clinical programs and partnerships with ACOs and Health Systems.

  • Business Unit Head, Clinical Trials Services BU

    Jan 2014 - Jan 2015

  • Vice President, Sales & Contracting Finance

    Jan 2012 - Jan 2014

  • Director, Clinical & Healthcare Partnership Finance

    Jan 2011 - Jan 2012
• 

  Astellas Pharmaceuticals

  Jan 2015 - Jan 2017

  Senior Director, Capacity, Metrics and Reporting

  Leader of performance metrics, reporting and capacity/resource planning for 470-person global clinical development organization. Objective for the function is to provide visualization of study-level execution risks, overall process performance, and areas of excess or strained labor capacity – enabling the operation to achieve increased speed and quality of execution, while reducing cost, through real-time interventions, process improvements and more efficient resource utilization. Reported to SVP, Global Development Operations. Show less

• 

  GE HealthCare Command Center

  Jan 2017 - Jan 2018

  Partnership Valuation Leader

  Value creation architect for outcomes-based partnerships between GE and major health systems. The role requires working with the partner and internal stakeholders to agree upon a quantification of each partners projected impact, and to establish post-deal performance reporting metrics and tools. Each partnership has the potential to deliver $100M+ in shared value over the life of the deal.

• 

  AltaThera Pharmaceuticals

  Jan 2018 - Jan 2022

  Chief Financial Officer

  Provided leadership of Finance, Accounting and Control, Business Planning/Analytics, Sales Forecasting, Supply Chain, Distribution and Government Contracting functions for this commercial-stage specialty pharmaceutical company.

• 

  Neuralstem, Inc.

  Jan 2018 - Jan 2019

  Interim CEO

  Interim CEO and Chief Accounting Officer for this publicly traded late-clinical-stage CNS biotechnology company.

• 

  AVM Biotechnology

  Jan 2022 - Jan 2023

  Chief Financial Officer